DERMA (Design of Enabling Regenerative Materials) is an E2.7m EU Interreg 2 Seas project that has received funding from the European Regional Development Fund. The objective of DERMA is to develop new interventions for the management and treatment of dermal ulcers, other chronic non-healing wounds, and related skin conditions, including stomas.
DERMA will design, develop and evaluate two novel wound dressings incorporating marine-sourced polymers – an odour-absorbing and antimicrobial wound dressing and a diagnostic wound dressing with the diagnostic capability to indicate wound status.
The project will address the common challenge of improving the quality of life of the increasing elderly population of the 2 Seas area. It will use the expertise of clinicians and designers from the outset, to transfer and advance our existing novel technologies to more refined products in response to market demands and patient needs.
Product prototypes will be supported with instructional computer animations and films for end-users. Design progress and route-to- market will be documented using video diaries as an educational tool for other developers and users. Innovative communication methods will be used by the partners to collaborate on large scale public events to showcase D-STEM-B research in action.
By addressing market and patient need, the project will deliver advanced new technologies ready for exploitation by industry. Beneficiaries will be patients (improved treatment and quality of life), healthcare providers (better treatment options and cost savings), and regional industry (boost for innovation, blue economy and sales).
The two main scientific outputs of DERMA are:
- Design, development and evaluation of an odour-absorbing and antimicrobial wound dressing (OAAWD)
- Design, development and evaluation of a diagnostic wound dressing (DWD) with diagnostic capability to indicate wound status
The project will progressively be able to deliver intermediary outputs, including:
- Design of final prototypes of the OAAWD and the DWD visualised by a computer animation depicting functionality and then sent to a large panel of stakeholders
- Prototypes of the OAAWD and of the DWD incorporating the previously elected designs and tested for functionality which will be displayed in Portsmouth’s public dissemination event and in the project’s closure event in Lille
- Route-to-market action plans for the OAAWD and DWD in order to be assured of the good delivery of project’s results
- Portfolios containing technical and legislative information on the OAAWD and the DWD freely available for any of match-making sessions’ participants, potentially over 120 SMEs.
Explore more of our research
Clinical Outcome Modelling
We're exploring ways of analysing health data to better calculate the risks patients face, and to evaluate new and improved techniques for managing patient care.
We're investigating targeted drug delivery systems using nanoparticles, finding new ways to deliver active molecules in medicines to the right part of the body – at the right time, in the right amounts – and identifying drugs that can be 'repurposed' to treat other diseases.